decisionhealth Newsletters, Answer Books - 2006 Issue 3 (March)
Program_Memos / 2000 / B-00-63
Subscribe or sign in to view the full article.
Article Overview
This Medicare Program Memorandum from HCFA/HHS explains a clarification related to flu vaccine payment allowance methodology and claim handling. It is relevant to Medicare carriers, billing staff, and coding professionals who follow drug and biological payment guidance and need to understand the scope of the update, timing notes, and related administrative instructions.
Why This Topic Matters
The memo affects how Medicare flu vaccine claims are evaluated under payment-limit methodology and helps ensure consistent processing when product availability changes. It also provides administrative guidance on previously processed claims and the memo’s duration of use.
What You Will Learn
- The administrative context and purpose of the memorandum
- How the update relates to Medicare payment-limit methodology for drugs and biologicals
- How claims already processed under the earlier approach are addressed
- The memo’s implementation, retention, and contact information notes
Who Should Read This
- Medicare carriers
- Billing staff
- Medical coders
- Revenue cycle professionals
- Compliance staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com